ASAN three-lens brief
Evidence-based stock research on ASAN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +2.29% yesterday. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Moved +2.29% yesterday.
- Outperforming SPY by 16.7pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Debt-to-equity of 248% — balance-sheet-heavy.
- Earnings scheduled 2026-12-01.
ASAN closed at $9.81 (+2.29%) as of 2026-11-12. Market cap: $2.25B. Price is below the 50-day MA and above the 200-day MA. Positives: moved +2.29% yesterday.; outperforming SPY by 16.7pp over 30 days.. Concerns: currently unprofitable on a trailing basis — no P/E multiple available.; debt-to-equity of 248% — balance-sheet-heavy.. Last quarter: Revenue $216.43M, net income -$39.19M, free cash flow $197.05M. Watching for: 2026-12-01 earnings release (19 days out).
Why three lenses on ASAN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ASAN across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ASAN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ASAN brief"></iframe>